Technical Outlook And Game Plan For Amneal Pharmaceuticals Inc (NASDAQ: AMRX)
The Vanguard Group, Inc. has recently announced that it has increased stake in Amneal Pharmaceuticals Inc (NASDAQ:AMRX) by 3.16%. After grabbing 13.25 million shares, the institutional investor is now in possession of 0.41 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 4.32% having worth around $57.09 million. […]